FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Rebecca Ricklis

Research Profile

Chemicals & Drugs

Procedures

Disorders

Living Beings

Mouse

Anatomy

Tumor Cells, Cultured

Concepts & Ideas

Co-author Network

Publications

TOP 3
Abeer Abd Elmoneim; Jessica Boklan; Todd Cooper; Lia Gore; Aru Narendran; Rebecca M Ricklis; Katherine Rolla; Tammy Scott; Robert J Arceci
Phase I dose-escalation trial of clofarabine followed by escalating doses of fractionated cyclophosphamide in children with relapsed or refractory acute leukemias.
Amer M Zeidan; Hetty Carraway; Douglas E Gladstone; Steven D Gore; Jacqueline M Greer; Mark Levis; A MICHAEL MCDEVITT; Keith William Pratz; Rebecca M Ricklis; Margaret Mary Showel; B Douglas Smith; Hyun D Yun; Judith E Karp
Phase 1 dose-escalation trial of clofarabine followed by escalating dose of fractionated cyclophosphamide in adults with relapsed or refractory acute leukaemias.
Sarah Reinhardt; Ming Zhao; Aleksander Mnatsakanyan; Linping Xu; Rebecca M Ricklis; Alice Chen; Judith E Karp; MICHELLE RUDEK-RENAUT
A rapid and sensitive method for determination of veliparib (ABT-888), in human plasma, bone marrow cells and supernatant by using LC/MS/MS.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Rebecca Ricklis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Abeer Abd Elmoneim; Jessica Boklan; Todd Cooper; Lia Gore; Aru Narendran; Rebecca M Ricklis; Katherine Rolla; Tammy Scott; Robert J Arceci
Phase I dose-escalation trial of clofarabine followed by escalating doses of fractionated cyclophosphamide in children with relapsed or refractory acute leukemias.
Pediatric blood & cancer 2012;59(7):1252-8.
2012: Amer M Zeidan; Hetty Carraway; Douglas E Gladstone; Steven D Gore; Jacqueline M Greer; Mark Levis; A MICHAEL MCDEVITT; Keith William Pratz; Rebecca M Ricklis; Margaret Mary Showel; B Douglas Smith; Hyun D Yun; Judith E Karp
Phase 1 dose-escalation trial of clofarabine followed by escalating dose of fractionated cyclophosphamide in adults with relapsed or refractory acute leukaemias.
British journal of haematology 2012;158(2):198-207.
2010: Sarah Reinhardt; Ming Zhao; Aleksander Mnatsakanyan; Linping Xu; Rebecca M Ricklis; Alice Chen; Judith E Karp; MICHELLE RUDEK-RENAUT
A rapid and sensitive method for determination of veliparib (ABT-888), in human plasma, bone marrow cells and supernatant by using LC/MS/MS.
Journal of pharmaceutical and biomedical analysis 2010;52(1):122-8.
2009: Judith E Karp; Karen Flatten; Eric J Feldman; Jacqueline M Greer; David A Loegering; Rebecca M Ricklis; Lawrence E Morris; Ellen Ritchie; B Douglas Smith; Valerie Ironside; Timothy Talbott; Gail Roboz; Son B Le; Xue Wei Meng; Paula A Schneider; Nga T Dai; Alex A. Adjei; Steven D Gore; Mark Levis; John J Wright; Elizabeth Garrett-Mayer; Scott H Kaufmann
Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposide.
Blood 2009;113(20):4841-52.
2007: Judith E Karp; Rebecca M Ricklis; Kumudha Balakrishnan; Janet Briel; Jacqueline Greer; Steven D Gore; B Douglas Smith; A MICHAEL MCDEVITT; Hetty Carraway; Mark Levis; Varsha Gandhi
A phase 1 clinical-laboratory study of clofarabine followed by cyclophosphamide for adults with refractory acute leukemias.
Blood 2007;110(6):1762-9.
2006: Saurabh Aggarwal; Rebecca M Ricklis; Simon A Williams; Samuel R Denmeade
Comparative study of PSMA expression in the prostate of mouse, dog, monkey, and human.
The Prostate 2006;66(9):903-10.
2006: Samuel Janssen; D Marc Rosen; Rebecca M Ricklis; Craig Dionne; Hans Lilja; S Brøgger Christensen; John T Isaacs; Samuel R Denmeade
Pharmacokinetics, biodistribution, and antitumor efficacy of a human glandular kallikrein 2 (hK2)-activated thapsigargin prodrug.
The Prostate 2006;66(4):358-68.
2004: Samuel Janssen; Carsten M Jakobsen; D Marc Rosen; Rebecca M Ricklis; Ulrich Reineke; S Brøgger Christensen; Hans Lilja; Samuel R Denmeade
Screening a combinatorial peptide library to develop a human glandular kallikrein 2-activated prodrug as targeted therapy for prostate cancer.
Molecular cancer therapeutics 2004;3(11):1439-50.
2003: Samuel R Denmeade; Lori J Sokoll; Susan L Dalrymple; D Marc Rosen; Alyssa M Gady; Debra J Bruzek; Rebecca M Ricklis; John T Isaacs
Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
The Prostate 2003;54(4):249-57.